Clinical Data Management Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Currently enrolled in a Master’s program for Health/Life Sciences, Health Administration, Public Health, or Epidemiology with an expected graduation date of Dec. 2026 – May 2027
Knowledge of Excel or PowerBI
Exposure to programming languages such as R, Python, or SQL
Aptitude for applying technology solutions to business problems
Strong Analysis/Problem Assessment Skills
Well-developed written and verbal communication skills
Demonstrated Teamwork/Interpersonal Skills
Leadership experience inside and/or outside the classroom
Scientific/laboratory/healthcare background and/or experience

Responsibilities

Develop an understanding of processes and procedures within the Data and Analytics business unit
Understand database structure, content and meaning
Identify key data points and trends in data entry
Develop metrics and ad-hoc reports for clinical trials
Analyze clinical data reports to determine points of interest
Assist clinical study teams in maintaining overall trial health and meeting deadlines
Develop and implement solutions to improve data efficiencies
Aid study teams in managing ongoing clinical research or work on innovation projects within clinical data management
Present project highlights, findings and general accomplishments to Clinical Data Sciences professionals

Skills

Clinical Data Management

Data Collection

Data Flow Management

Data Quality

Data Standards

Data Technology

Dataset Delivery

Clinical Trials

Project Management

Automation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free